Viewing Study NCT02538627


Ignite Creation Date: 2025-12-25 @ 5:09 AM
Ignite Modification Date: 2025-12-26 @ 4:14 AM
Study NCT ID: NCT02538627
Status: TERMINATED
Last Update Posted: 2017-09-05
First Post: 2015-08-31
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Phase 1 Combination Study of MM-151 With MM-121, MM-141, or Trametinib
Sponsor: Merrimack Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module